Rituximab is a monoclonal antibody used to treat certain cancers and autoimmune diseases. It is a pharmaceutical agent administered via IV, designed to target CD20 on B-cells. In medical contexts, it’s discussed as a biologic therapy with specific dosing regimens and monitoring requirements.
Full pronunciation guide
